Burg Simpson is investigating potential product liability claims on behalf of women who suffered meningioma tumors after using Depo Provera.
UPDATE 2-18-2025: On February 7, 2025, the Judicial Panel on Multidistrict Litigation (JPML) granted a motion to consolidate all Depo Provera meningioma lawsuits in one court. Judge M. Casey Rodgers in the Northern District of Florida will preside over the multidistrict litigation. Multidistrict litigation groups similar civil lawsuits into one federal district court and is often used in pharmaceutical product liability cases. Although the cases are coordinated in one court, they remain individual lawsuits.
To learn more about the Depo Provera litigation and how Burg Simpson can help you, please continue reading below.
What is a Meningioma?
A meningioma is a type of benign tumor that can form near the brain or spinal cord. Meningioma tumors grow from membranes, known as meninges, surrounding the brain and spinal cord. Most meningiomas are slow growing and can put pressure on the nearby brain, nerves, and vessels leading to symptoms such as headaches, weakness in arms or legs, vision problems, seizures, memory loss, and/or personality changes. Although meningiomas are non-cancerous, surgery may be required to remove the tumor.
What is Depo Provera?
Depo Provera (medroxyprogesterone acetate) is a progestin only based hormonal birth control. Depo Provera is an injection given every three months, usually at your doctor’s office or at a local pharmacy. Depo Provera is an intramuscular injection given in your buttock or upper arm.
Studies Show An Increased Risk Of Meningioma Tumors In The Brain After Depo Provera Use
Recent medical studies have shown that women who use Depo Provera, as opposed to other hormonal contraceptives, are at an increased risk of meningioma tumors developing in the brain. The risk of such tumors also increases the longer you use Depo Provera.
In a recent French study, published in the British Medical Journal, users of Depo Provera were found to have the highest risk of meningiomas (odds ratio 5.55) among users of certain progesterone only containing contraceptives.
A recent study published in the United States confirmed that women who receive Depo Provera via intramuscular injection versus oral pills were at an increased risk of meningiomas (odds ratio 1.53). Moreover, the risk increased with longer duration use of the injections.
The manufacturers of Depo Provera have yet to add a warning to their approved drug label to warn women of the increased risk of meningiomas.
Lawsuits Are Being Filed Against the Makers of Depo Provera
Dozens of lawsuits have already been filed against the manufacturers of Depo Provera to hold them accountable for the increased risks associated with the injection birth control. Time limits exist for you to file a lawsuit, so don’t delay speaking with one of our experienced attorneys.
Contact Burg Simpson Today
If you or someone you know used Depo Provera and was diagnosed with a meningioma tumor, contact the experienced product liability attorneys at Burg Simpson today. We are here to help you. Call 888-895-2080 or fill out our contact form for a FREE no-obligation consultation with one of our lawyers today.
